-
Forward Look
More Treatments Approved for Metastatic Breast CancerTargeted therapy approvals increase options and hope for some patients.
by Cameron Walker
-
Forward Look
Cancer Death Rate Decline Makes HeadlinesExperts say it's necessary to look behind the statistics.
by Delia O’Hara
-
Robotic Surgery and CancerUsing robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.
by Sue Rochman
-
Treating Cancer Patients With COVID-19: A New York City ExperienceAn analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
-
What is a Super Responder?Researchers are investigating why certain patients have an exceptional response to a particular drug.
by Bradley Jones
-
Pediatric Oncologists Underestimate Needs of Minority ParentsResearch describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.
by Marci A. Landsmann
-
COVID-19 Exposes Health InequitiesAt a symposium held during a virtual meeting of cancer researchers, panelists discussed the disproportionate impact COVID-19 has had on Black and Latino Americans, as well as members of other minority groups.
by Kevin McLaughlin
-
Pushing Progress ForwardNCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”
by Kevin McLaughlin
-
Cancer and Older Adults: Can Oncologists Do Better?Geriatric assessment reduces toxicity from treatment and improves quality of life in older adults with cancer.
by Marci A. Landsmann
-
Why Skip a Dose?A survey of over 1,000 breast cancer patients prescribed endocrine therapy sheds light on low adherence.
by Emma Yasinski
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
